N-linked glycosylation selectively regulates autonomous precursor BCR function

Nature Immunology

Volumn 11, Issue 8, 2010, Pages 759-765

  Übelhart, Rudolf ^a,b   Bach, Martina P ^a,b   Eschbach, Cathrin ^a,b   Wossning, Thomas ^a,b,c   Reth, Michael ^a,b   Jumaa, Hassan ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c Centro Nacional de Investigaciones Oncológicas   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CROSS LINKING; GLYCOSYLATION; HEAVY CHAIN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ASPARAGINE; B-LYMPHOCYTES; GLYCOSYLATION; IMMUNOGLOBULIN HEAVY CHAINS; MICE; MICE, KNOCKOUT; PRE-B CELL RECEPTORS; RECEPTORS, ANTIGEN, B-CELL;

EID: 77954957121     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1903     Document Type: Article

References (40)

1. Burrows, P.D. et al. The transient expression of pre-B cell receptors governs B cell development. Semin. Immunol. 14, 343-349 (2002).
2. Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K.A. B cell-defcient mouse by targeted disruption of the membrane exon of the immunoglobulin |i chain gene. Nature 350, 423-426 (1991).
3. Kitamura, D. et al. A critical role of X5 protein in B cell development. Cell 69, 823-831 (1992).
4. Meixlsperger, S. et al. Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity 26, 323-333 (2007).
5. Geier, J.K. & Schlissel, M.S. Pre-BCR signals and the control of Ig gene rearrangements. Semin. Immunol. 18, 31-39 (2006).
6. Gauthier, L, Rossi, B., Roux, F., Termine, E. & Schiff, C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc. Natl. Acad. Sci. USA 99, 13014-13019 (2002).
7. Bradl, H., Wittmann, J., Milius, D., Vettermann, C. & Jack, H.M. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of X5 and stroma cell-associated heparan sulfate. J. Immunol. 171, 2338-2348 (2003).
8. Bankovich, A.J. et al. Structural insight into pre-B cell receptor function. Science 316, 291-294 (2007).
9. Rolink, A.G., Winkler, T., Melchers, F. & Andersson, J. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J. Exp. Med. 191, 23-32 (2000).
10. Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
11. Kohler, F. et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity 29, 912-921 (2008).
12. Moody, A.M. et al. Sialic acid capping of CD8p core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. J. Biol. Chem. 278, 7240-7246 (2003).
13. Tedder, T.F., Tuscano, J., Sato, S. & Kehrl, J.H. CD22, a B lymphocyte-specifc adhesion molecule that regulates antigen receptor signaling. Annu. Rev. Immunol. 15, 481-504 (1997).
14. Ghosh, S., Bandulet, C. & Nitschke, L. Regulation of B cell development and B cell signalling by CD22 and its ligands a2,6-linked sialic acids. Int. Immunol. 18, 603-611 (2006).
15. Nimmerjahn, F. & Ravetch, J.V. Anti-infammatory actions of intravenous immunoglobulin. Annu. Rev. Immunol. 26, 513-533 (2008).
16. Kaneko, Y., Nimmerjahn, F. & Ravetch, J.V. Anti-infammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313, 670-673 (2006).
17. Wang, F., Nakouzi, A., Angeletti, R.H. & Casadevall, A. Site-specifc characterization of the N-linked oligosaccharides of a murine immunoglobulin M by high-performance liquid chromatography/electrospray mass spectrometry. Anal. Biochem. 314, 266-280 (2003).
18. Wright, J.F., Shulman, M.J., Isenman, D.E. & Painter, R.H. C1 binding by mouse IgM. The effect of abnormal glycosylation at position 402 resulting from a serine to asparagine exchange at residue 406 of the i-chain. J. Biol. Chem. 265, 10506-10513 (1990).
19. Muraoka, S. & Shulman, M.J. Structural requirements for IgM assembly and cytolytic activity. Effects of mutations in the oligosaccharide acceptor site at Asn402. J. Immunol. 142, 695-701 (1989).
20. Lutz, C. et al. IgD can largely substitute for loss of IgM function in B cells. Nature 393, 797-801 (1998).
21. Kim, K.M. et al. Anti-IgM but not anti-IgD antibodies inhibit cell division of normal human mature B cells. J. Immunol. 148, 29-34 (1992).
22. Kim, K.M. & Reth, M. The B cell antigen receptor of class IgD induces a stronger and more prolonged protein tyrosine phosphorylation than that of class IgM. J. Exp. Med. 181, 1005-1014 (1995).
23. Tisch, R., Roifman, CM. & Hozumi, N. Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc. Natl. Acad. Sci. USA 85, 6914-6918 (1988).
24. Jumaa, H. et al. Abnormal development and function of B lymphocytes in mice defcient for the signaling adaptor protein SLP-65. Immunity 11, 547-554 (1999).
25. Flemming, A., Brummer, T., Reth, M. & Jumaa, H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat. Immunol. 4, 38-43 (2003).
26. Hu, CD., Chinenov, Y. & Kerppola, T.K. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fuorescence complementation. Mol. Cell 9, 789-798 (2002).
27. Su, Y.W. et al. Identifcation of a pre-BCR lacking surrogate light chain. J. Exp. Med. 198, 1699-1706 (2003).
28. Galler, G.R. et al. Surface |i heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components. J. Exp. Med. 199, 1523-1532 (2004).
29. Schuh, W., Meister, S., Roth, E. & Jack, H.M. Cutting edge: signaling and cell surface expression of a JI H chain in the absence of X5: a paradigm revisited. J. Immunol. 171, 3343-3347 (2003).
30. Su, Y.W. & Jumaa, H. LAT links the pre-BCR to calcium signaling. Immunity 19, 295-305 (2003).
31. Minegishi, Y., Hendershot, L.M. & Conley, M.E. Novel mechanisms control the folding and assembly of X5/14.1 and VpreB to produce an intact surrogate light chain. Proc. Natl. Acad. Sci. USA 96, 3041-3046 (1999).
32. Ohnishi, K. & Melchers, F. The nonimmunoglobulin portion of lambda5 mediates cell-autonomous pre-B cell receptor signaling. Nat. Immunol. 4, 849-856 (2003).
33. Guloglu, F.B. & Roman, C.A. Precursor B cell receptor signaling activity can be uncoupled from surface expression. J. Immunol. 176, 6862-6872 (2006).
34. ten Boekel, E., Melchers, F. & Rolink, A.G. Precursor B cells showing H chain allelic inclusion display allelic exclusion at the level of pre-B cell receptor surface expression. Immunity 8, 199-207 (1998).
35. Pelanda, R. et al. Receptor editing in a transgenic mouse model: site, effciency, and role in B cell tolerance and antibody diversifcation. Immunity 7, 765-775 (1997).
36. Waisman, A. et al. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig a/p. J. Exp. Med. 204, 747-758 (2007).
37. Shaner, N.C. et al. Improved monomeric red, orange and yellow fuorescent proteins derived from Discosoma sp. red fuorescent protein. Nat. Biotechnol. 22, 1567-1572 (2004).
38. Ketteler, R., Glaser, S., Sandra, O., Martens, U.M. & Klingmuller, U. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells effciently transduced by optimized retroviral hybrid vectors. Gene Ther. 9, 477-487 (2002).
39. Storch, B., Meixlsperger, S. & Jumaa, H. The Ig-α ITAM is required for effcient differentiation but not proliferation of pre-B cells. Eur. J. Immunol. 37, 252-260 (2007).
40. Minguet, S., Swamy, M., Alarcon, B., Luescher, I.F. & Schamel, W.W. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 26, 43-54 (2007).